IBD prevalence rates exhibited an increasing trend across all insurance premium groups, with the groups paying the highest premiums showing the highest rates (Fig. 1 C).
← all excerpts
Epidemiology of diagnosed inflammatory bowel disease in Taiwan population from 2011 to 2021: a population-based study.
1
—
—